Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $18.37, but opened at $19.96. Ascentage Pharma Group International shares last traded at $20.05, with a volume of 23,192 shares changing hands.
Wall Street Analyst Weigh In
Separately, JPMorgan Chase & Co. started coverage on shares of Ascentage Pharma Group International in a research report on Thursday. They set an “overweight” rating for the company.
View Our Latest Stock Analysis on AAPG
Ascentage Pharma Group International Stock Performance
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
- Five stocks we like better than Ascentage Pharma Group International
- Profitably Trade Stocks at 52-Week Highs
- CarMax and Carvana: Steering the Used Car Market
- What is the Nasdaq? Complete Overview with History
- How China’s Recovery Could Boost These 3 Platinum Plays
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Fortinet: A Top Cybersecurity Stock With Growth Catalysts
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
